Skip to main content

Kinled Holding — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

39
Companies
$2.3B
Total invested
$54.0M
Avg. check
46
Industries
Health Care 7Biotechnology 7Financial Services 6FinTech 5Medical Device 5Therapeutics 4+40 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 39
DF Capital
September 2023

DF Capital builds relationships with manufacturers and provides working capital solutions up and down supply chains.

Finance · Manchester$24.9M Debt Financing
Sympatient
September 2022

An operating system for modern psychotherapy - combining care structures and technology within regulated healthcare for better results.

Health Care · Hamburg$7.4M Series A
Muse Finance
August 2022

Tech platform that matches supply and demand for working capital

Financial Exchanges · London$20.0M Debt Financing
Peerbridge Health
August 2025

Peerbridge Health offers a wearable ECG platform that uses AI to detect heart failure, sleep apnea, and ejection fraction changes.

Artificial Intelligence (AI) · New York$7.2M Venture - Series Unknown
Agro.Club
July 2021

Agro.Club is a full-stack B2B global marketplace operating in the world’s key grain regions.

Agriculture · New York$5.0M Series A
Cornea Sense
July 2026

CorneaSense is a medtech startup developing a non-invasive eye sensor to measure ocular hydration for early disease detection.

Health Diagnostics · Espoo$1.3M Pre-Seed
Nanoflex Robotics
June 2026

Nanoflex Robotics develops a telerobotic platform that enables remote treatment of ischemic strokes

Health Care · OpfikonVenture - Series Unknown
Engimmune Therapeutics
May 2022

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Biotechnology · Basel$15.8M Seed
Adsum
May 2022

London-based fintech specialising in Instant VAT refunds, R&D and Creative Industry Tax Credits for UK businesses.

Financial Services · London$5.0M Seed
Accure Therapeutics
April 2025

Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.

Biotechnology · Barcelona$1.6M Grant
AdaptHealth
April 2026

AdaptHealth is a provider of home healthcare equipment, medical supplies to the home and related services in the United States.

Health Care · Phoenixville$1.1B Post-IPO Debt
Social Snowball
February 2024

Social Snowball provides a marketing platform that enables eCommerce brands to automate affiliate, influencer, and referral programs.

Advertising · Miami$430K Seed
Wiredirect
February 2022

Wiredirect is a global financial technology and FX liquidity firm that facilitates payments across borders.

Financial Services · London$1.7M Series A
cofenster
February 2022

AI Video Assistants for your enterprises

Software · Hamburg$9.1M Series A
Accelus
May 2025

Accelus is an minimally invasive spine surgery through its procedure-enabling technology.

Health Care · Palm Beach Gardens$6.1M Venture - Series Unknown
Xapien
July 2024

Xapien automates online research, using Artificial Intelligence, Natural Language Processing & with vast cloud compute power: #XapienThem

Financial Services · London$10.4M Series A
PreComb
December 2024

PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.

Biotechnology · HombrechtikonSeries A
Bricksave
December 2022

Real Estate Crowdfunding Platform

Crowdfunding · London$6.0M Series A
Nuuron
October 2024

Nuuron is a neurotech startup.

Biotechnology · Berlin$3.8M Seed
Lopay
October 2023

Lopay gives you more control, more flexibility, and instant access to the money you earn.

Financial Services · London$7.4M Seed
Planetly
April 2021

Planetly is building the software to analyze, reduce and offset your carbon footprint.

Environmental Consulting · BerlinSeries Unknown
Eirion Therapeutics
March 2021

Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.

Biotechnology · Woburn$40.0M Series A
Herophilus
January 2021

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.

Biotechnology · San Francisco$16.0M Seed
Calyxha Biotechnologies
February 2020

Calyxha is developing novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases.

Biotechnology · Vienna$1.1M Seed

Where Kinled Holding invests

Health Care7
Biotechnology7
Financial Services6
FinTech5
Medical Device5
Therapeutics4

About Kinled Holding's portfolio

How many companies has Kinled Holding invested in?▸

Kinled Holding has invested in 39 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Kinled Holding invest in?▸

Kinled Holding's top investment sectors include Health Care, Biotechnology, Financial Services, FinTech, Medical Device. The firm invests across 46 different industry categories.

What is Kinled Holding's largest investment?▸

Among tracked funding rounds, AdaptHealth received $1.1B in a Post-IPO Debt round. Kinled Holding's total known invested capital is $2.3B.

What is the average investment size for Kinled Holding?▸

Kinled Holding's average investment size is $54.0M across its portfolio of 39 companies.

What are Kinled Holding's most recent investments?▸

Recent Kinled Holding portfolio additions include DF Capital, Sympatient, Muse Finance, Peerbridge Health, Agro.Club. These companies were founded in 2020 or later.

Reach the founders behind these 39 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →